Autoantibody Biomarkers in Rheumatic Diseases

Area of Science:

• Immunology
• Rheumatology
• Clinical Diagnostics

Background:

• Autoantibodies serve as crucial biomarkers in systemic rheumatic diseases.
• They aid in diagnosis, predicting clinical phenotypes, prognosis, and treatment decisions.
• Emerging evidence shows autoantibodies actively participate in disease pathogenesis.

Purpose of the Study:

• To review current understanding of autoantibodies in four major rheumatic diseases.
• To highlight advancements in their biological effects and clinical utility.
• To consolidate knowledge on autoantibodies as diagnostic and prognostic tools.

Main Methods:

• Literature review of recent research on autoantibodies.
• Focus on rheumatoid arthritis, myositis, systemic sclerosis, and ANCA-associated vasculitis.
• Analysis of biological roles and clinical applications of autoantibodies.

Main Results:

• Autoantibodies are significant indicators for diagnosis and prognosis in rheumatic diseases.
• Disease-specific autoantibodies are involved in the active disease process.
• Progress has been made in understanding the clinical value and biological effects of these autoantibodies.

Conclusions:

• Autoantibodies are essential for understanding and managing systemic rheumatic diseases.
• Their role extends beyond mere association to active pathogenic involvement.
• Continued research on autoantibodies improves clinical practice and patient outcomes.